TSX tick higher after index ends prior session near two-week high
Investing.com -- Fujifilm’s stock closed down 3% on Thursday following the company’s second-quarter earnings announcement.
The company reported that its second-quarter operating profit exceeded internal plans by ¥8-9 billion, excluding foreign exchange effects. This outperformance was driven by strong results in the Imaging, Electronics, and Business Innovation (BI) segments.
However, the Healthcare segment fell short of expectations, primarily due to higher silver prices affecting the medical space. The company’s Contract Development and Manufacturing Organization (CDMO) second-quarter profit was in line with its plan, as improvements in large-scale operations offset delays in small and mid-size operations.
Fujifilm revised its operating profit guidance, increasing the Imaging segment by ¥10 billion while reducing both Healthcare and Business Innovation segments by ¥5 billion each.
The company noted that camera demand remains strong globally, with new products contributing positively to performance. In the medical sector, robust growth in endoscopes is expected to offset weakness in China’s medical consumables market.
For the second half of the fiscal year, Fujifilm expects CDMO profit performance to be similar to the first half. The company has increased capital expenditure plans for NCP1 and Denmark P2 facilities, though the resulting incremental depreciation for the current year is expected to be minor.
Fujifilm maintained its foreign exchange assumptions for the third quarter onward at ¥145 per USD and ¥155 per EUR. The company plans to present its outlook for the next fiscal year at its 2026 business briefing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.